VeriSign Total Cost of Revenue increased by 0.4% to $49.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.4%, from $49.40M to $49.20M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows relatively stable performance with a 0.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.80M | $47.80M | $49.30M | $50.70M | $49.50M | $50.00M | $50.50M | $49.90M | $50.30M | $48.60M | $48.50M | $49.10M | $47.10M | $46.80M | $48.40M | $49.40M | $49.10M | $48.80M | $49.00M | $49.20M |
| QoQ Change | — | +0.0% | +3.1% | +2.8% | -2.4% | +1.0% | +1.0% | -1.2% | +0.8% | -3.4% | -0.2% | +1.2% | -4.1% | -0.6% | +3.4% | +2.1% | -0.6% | -0.6% | +0.4% | +0.4% |
| YoY Change | — | — | — | — | +3.6% | +4.6% | +2.4% | -1.6% | +1.6% | -2.8% | -4.0% | -1.6% | -6.4% | -3.7% | -0.2% | +0.6% | +4.2% | +4.3% | +1.2% | -0.4% |